Fei Ren
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Genetic factors in colorectal cancer 5
- Oncology 11
- Colorectal Cancer Treatments and Studies 4
- Co-authors
- Yingtang Zhou (2 shared papers)Xiangjiao Meng (3 shared papers)Hongwei Cai (4 shared papers)Bei Sun (4 shared papers)Jinming Yu (1 shared paper)Ming‐Guo Liu (1 shared paper)Huan Ye (3 shared papers)Hao Ou (3 shared papers)
- Journals
- Scientific Reports (2 papers)Molecular Pain (1 paper)Journal of Neurophysiology (1 paper)Frontiers in Immunology (1 paper)Journal of Neuro-Oncology (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Fei Ren
37 papers receiving 991 citations
Peers
Comparison fields: 5 of 100
- Oncology 382
- Cancer Research 173
- Neurology 66
- Developmental Neuroscience 29
- Immunology 140
Countries citing papers authored by Fei Ren
This map shows the geographic impact of Fei Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Ren more than expected).
Fields of papers citing papers by Fei Ren
This network shows the impact of papers produced by Fei Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Ren. The network helps show where Fei Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 155 | |
| 2 | 2013 | 131 | |
| 3 | 2018 | 95 | |
| 4 | 2020 | 76 | |
| 5 | 2013 | 67 | |
| 6 | MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer. | 2015 | 51 |
| 7 | 2018 | 46 | |
| 8 | 2016 | 36 | |
| 9 | 2017 | 34 | |
| 10 | 2015 | 33 | |
| 11 | 2020 | 29 | |
| 12 | 2019 | 27 | |
| 13 | 2017 | 23 | |
| 14 | 2015 | 22 | |
| 15 | 2014 | 21 | |
| 16 | 2021 | 21 | |
| 17 | 2022 | 16 | |
| 18 | 2021 | 16 | |
| 19 | 2018 | 15 | |
| 20 | 2020 | 12 |
About Fei Ren
Fei Ren is a scholar working on Pathology and Forensic Medicine, Oncology, Molecular Biology, Surgery and Psychiatry and Mental health, having authored 40 papers that have together received 1.0k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer-related molecular mechanisms research (4 papers), Migraine and Headache Studies (3 papers), RNA modifications and cancer (3 papers), Autophagy in Disease and Therapy (3 papers), Nerve injury and regeneration (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Oncology (382 citations), Cancer Research (173 citations), Neurology (66 citations), Developmental Neuroscience (29 citations) and Immunology (140 citations). Fei Ren has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Yingtang Zhou, Xiangjiao Meng, Hongwei Cai, Bei Sun, Jinming Yu, Ming‐Guo Liu, Huan Ye, Hao Ou, Weiqi Sheng and Tao Zhong. Their work appears in journals such as Scientific Reports, Molecular Pain, Journal of Neurophysiology, Frontiers in Immunology and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.